XOI: 1-[(5M,8aS,13R)-5-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-2-{[(2S,4R)-4-fluoro-1-methylpyrrolidin-2-yl]methoxy}-8a,9,11,12-tetrahydropyrazino[2',1':3,4][1,4]oxazepino[5,6,7-de]quinazolin-10(8H)-yl]prop-2-en-1-one
XOI is a Ligand Of Interest in 8UN3 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8UN3_XOI_C_201 | 89% | 51% | 0.099 | 0.979 | 0.66 | 1.21 | 1 | 3 | 1 | 0 | 100% | 1 |
| 8UN3_XOI_D_201 | 88% | 54% | 0.103 | 0.979 | 0.6 | 1.15 | 1 | 2 | 0 | 0 | 100% | 1 |
| 8UN3_XOI_A_201 | 88% | 53% | 0.097 | 0.972 | 0.55 | 1.25 | - | 4 | 0 | 0 | 100% | 1 |
| 8UN3_XOI_B_201 | 87% | 60% | 0.102 | 0.976 | 0.53 | 0.98 | - | 2 | 1 | 0 | 100% | 1 |
